Product Information
ICOSAPENT ETHYL 1 GRAM CAPSULE is a generic product labeled by Apotex Corp., priced at $0.4408 per EA under NDC 60505403301. Its NADAC has been published 237 times since Mar 23, 2022.
FDA first approved this application on Jun 30, 2021. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
1 g/1
Manufacturer
Apotex Corp.NDC
60505403301
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
ICOSAPENT ETHYLApproval Type
Generic (ANDA)
FDA Application
ANDA209437FDA Approved
6/30/2021
TE Code
AB
On Market Since
12/16/2021
Price Statistics
The NADAC for ICOSAPENT ETHYL 1 GRAM CAPSULE has been published 237 times since Mar 23, 2022, and over the history we have for it it has declined 79.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.4408 per EA |
|---|---|
| All-time high | $2.1525 (May 11, 2022) |
| All-time low | $0.4408 (Sep 23, 2026) |
| 52-week high | $0.5153 |
| 52-week low | $0.4408 |
| Median price | $0.9230 |
| Average price | $1.0697 |
| Largest weekly change | +35.6% (Aug 21, 2024) |
| Weeks tracked | 237 |
| Tracking since | Mar 23, 2022 |
Generic Alternatives
The matcher finds 5 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Apotex Corp. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Icosapent Ethyl market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of ICOSAPENT ETHYL 1 GRAM CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for ICOSAPENT ETHYL 1 GRAM CAPSULE, manufactured by Apotex Corp., is $0.4408 per EA (NDC 60505403301), effective Sep 30, 2026.
How has the price of ICOSAPENT ETHYL 1 GRAM CAPSULE changed over time?
Over the history we have for it, the NADAC for ICOSAPENT ETHYL 1 GRAM CAPSULE has declined 79.2%. It has been tracked across 237 weekly CMS publications since Mar 23, 2022.
What are the highest and lowest recorded NADAC prices for ICOSAPENT ETHYL 1 GRAM CAPSULE?
Since Mar 23, 2022, the NADAC for ICOSAPENT ETHYL 1 GRAM CAPSULE has ranged from a low of $0.4408 (Sep 23, 2026) to a high of $2.1525 (May 11, 2022), with a median of $0.9230 per EA.
Are there cheaper alternatives to ICOSAPENT ETHYL 1 GRAM CAPSULE?
5 manufacturers publish a NADAC-priced product with the same active ingredient and strength as ICOSAPENT ETHYL 1 GRAM CAPSULE in a comparable dosage form, but none are currently priced below it.
Who manufactures ICOSAPENT ETHYL 1 GRAM CAPSULE?
ICOSAPENT ETHYL 1 GRAM CAPSULE (NDC 60505403301) is labeled by Apotex Corp., and CMS classifies it as a generic product.